RecruitingNCT04678011

A Personalized Surveillance and Intervention Protocol for Patients With Familial Adenomatous Polyposis That Have Undergone (Procto)Colectomy


Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Enrollment

1,000 participants

Start Date

Nov 24, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to determine the efficacy and safety of a personalised surveillance and intervention protocol for patients with familial adenomatous polyposis (FAP) that have undergone (procto)colectomy.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is developing a personalized surveillance and treatment protocol for patients with Familial Adenomatous Polyposis (FAP) — a hereditary condition that causes many polyps throughout the digestive tract — specifically for patients who have already had their colon or rectum surgically removed. Researchers want to improve how these patients are monitored after surgery to catch and manage any remaining polyps or cancer risk. **You may be eligible if you:** - Have been diagnosed with FAP (by genetic testing or clinical criteria) - Have already undergone surgical removal of your colon (and possibly rectum) - Are 18 years of age or older - Have no cancer detected at your baseline endoscopy after surgery **You may NOT be eligible if you:** - Have cancer detected at baseline endoscopy after surgery - Cannot have all polyps removed during clearing endoscopies - Currently require surgery Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREPersonalized surveillance and intervention protocol

This study uses one arm. Participants will undergo endoscopic surveillance with intervals between 6 months and 2 years, depending on severity of polyposis and performed endoscopic interventions.


Locations(2)

MD Anderson

Houston, Texas, United States

Academic Medical Centre

Amsterdam, North Holland, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04678011


Related Trials